03 Profile
Vital Signsby Bridgehead
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cancer
Hanny Al-Samkari: no photograph is held, so the academic plate is shown instead.
Academic
Hanny Al-Samkari
MD, classical hematologist at Mass General Brigham Cancer Institute and the Peggy S. Blitz Endowed Chair in Hematology/Oncology
1
0
0
0
1
0
0
0
0
Mar 2026AprMayJuneJulyAugSeptOctNovto date
2
press citations on 1 topic since 16 Mar 2026 · last quoted 28 Jul 2026
02 Quoted on · 1 of 29 topics
Hanny Al-Samkari: key facts
- Kind of voice
- Academic
- Role
- MD, classical hematologist at Mass General Brigham Cancer Institute and the Peggy S. Blitz Endowed Chair in Hematology/Oncology
- Quoted on
- Cancer
- Tracked press citations
- 2
- Most recently quoted
- 28 Jul 2026
- First quoted
- 16 Mar 2026
04 The signal · where Hanny Al-Samkari sits on cancer
Ranked 33= of 100 voices quoted in the press on cancer, level with 42 others on 2 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Prof Peter JohnsonClinicianNational Clinical Director for Cancer, NHS England15 - 2
Michelle MitchellSector leaderChief Executive, Cancer Research UK14 - 3=
Dr Ian WalkerSector leaderExecutive Director of Policy and Information, Cancer Research UK7 - 33=Professor Georgina LongClinicianMedical Director; Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia (MIA) / The University of Sydney / Royal North Shore Hospital2
- 33=David JamesSector leaderDirector of Patient Projects and Influencing, Prostate Cancer Research2
- 33=Hanny Al-SamkariAcademicMD, classical hematologist at Mass General Brigham Cancer Institute and the Peggy S. Blitz Endowed Chair in Hematology/Oncology2
- 33=Julie R. Gralow, MDAcademicChief medical officer and executive vice president of ASCO2
- 33=Dr Rachna ShroffClinicianChief, Division of Hematology and Oncology; Associate Director of Clinical Investigations, University of Arizona Cancer Center2
Showing the leaders and the ranks around 33=, of 100 voices · See every voice on the topic →
05 On the record · press
What Hanny Al-Samkari has said
By outlet · linked articles
- oncology-central.com2
Where Hanny Al-Samkari has been quoted
- 01Avatrombopag achieves 70% success rate in treating chemotherapy-induced thrombocytopeniaoncology-central.com · 28 Jul 2026
- 02Romiplostim shows promise in treating chemotherapy-induced thrombocytopeniaoncology-central.com · 16 Mar 2026
Verbatim
“The findings from our trial may help improve care for patients who experience persistent CIT, which has historically been a very challenging complication to manage”
“This work has been nearly a decade in the making, and it is so important because there are no available approved medications for chemotherapy-induced thrombocytopenia, which drastically increases a patient's risk of major or life-threatening bleeding.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.